These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 36300959)

  • 41. Fecal microbiota transplantation: a review on current formulations in
    Rakotonirina A; Galperine T; Allémann E
    Expert Opin Biol Ther; 2022 Jul; 22(7):929-944. PubMed ID: 35763604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease.
    Haifer C; Leong RW; Paramsothy S
    Curr Opin Pharmacol; 2020 Dec; 55():8-16. PubMed ID: 33035780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoring the gut microbiome for the treatment of inflammatory bowel diseases.
    Allegretti JR; Hamilton MJ
    World J Gastroenterol; 2014 Apr; 20(13):3468-74. PubMed ID: 24707129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal microbiota transplantation beyond Clostridioides difficile infections.
    Wortelboer K; Nieuwdorp M; Herrema H
    EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and
    Park SH; Lee JH; Kim JS; Kim TJ; Shin J; Im JH; Cha B; Lee S; Kwon KS; Shin YW; Ko SB; Choi SH
    Aging (Albany NY); 2022 Aug; 14(16):6449-6466. PubMed ID: 35980280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Cho S; Spencer E; Hirten R; Grinspan A; Dubinsky MC
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):343-347. PubMed ID: 30320666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
    Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L
    Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
    Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient].
    Tamura S; Ishida H; Shimizu T; Imaeda H; Nishida A; Bamba S; Andoh A; Iwasa Y; Kuroda H
    Rinsho Ketsueki; 2022; 63(3):217-223. PubMed ID: 35387936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection.
    Allegretti JR; Axelrad J; Dalal RS; Kelly CR; Grinspan A; Fischer M
    Am J Gastroenterol; 2024 Jul; 119(7):1433-1436. PubMed ID: 38501667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Gastroenterology; 2021 May; 160(6):1961-1969.e3. PubMed ID: 33444573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients.
    Conover KR; Absah I; Ballal S; Brumbaugh D; Cho S; Cardenas MC; Knackstedt ED; Goyal A; Jensen MK; Kaplan JL; Kellermayer R; Kociolek LK; Michail S; Oliva-Hemker M; Reed AW; Weatherly M; Kahn SA; Nicholson MR
    J Pediatr Gastroenterol Nutr; 2023 Apr; 76(4):440-446. PubMed ID: 36720105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.